In Korea, Rhus verniciflua Stokes is used to purge hardness, alleviate blood stasis, and treat cancer. However, the mechanisms of related anti-cancer activity are not fully understood in human cancer cells. This study investigated the anti-cancer effects and mechanisms of Rhus verniciflua Stokes on MDA-MB-231 human breast cancer cells and found that treatment with a Rhus verniciflua Stokes extract resulted in time-and concentration-responses that indicated growth inhibition of breast cancer cells by induced apoptosis. This was followed by a decrease in mitochondrial membrane potential; the activation of caspase-3, -8, and -9; and the up-regulation of tBid. Caspase-dependent apoptosis was induced through the inhibition of phosphatidylinositol 3-kinase (PI3K) and the Akt signaling pathway. This study provides evidence that Rhus verniciflua Stokes might be useful for the treatment of breast cancer. 
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Fig. 3. Activation of caspases and degradation of PARP by RVSE in MDA-MB-231 human breast cancer cells.
(A) Cells were treated with the indicated concentrations of RVSE for 48 h. The cells were lysed and then equal amounts of cell lysates were separated on SDS-polyacrylamide gels and transferred to membranes. The membranes were probed with the indicated antibodies and the proteins were visualized using an ECL detection system. Actin was used as an internal control. (B) Cells grown under the same conditions as (A) were collected and lysed. In order to assay in vitro caspase activity, aliquots of cell lysate were incubated at 37 for 1 h with DEVD-pNA, IETD-pNA, and LEHD-pNA as substrates for caspase-3, -8, and -9, respectively. Released fluorescence products were measured. Each point represents the mean±SD of representative experiments performed at least three times. A Student's t-test (*, p<0.05 vs. untreated control) was used for analysis of statistical significance of the results. (Fig. 6) . 
